PHARMAQ ANALYTIQ LIMITED

Company number SC267850

Date	Type	Description	View / Download
24 Feb 2020	MR04	Satisfaction of charge SC2678500006 in full	(1 page)
06 Jan 2020	TM01	Termination of appointment of Mark James Plampin as a director on 20 December 2019	(1 page)
05 Dec 2019	CS01	Confirmation statement made on 5 December 2019 with updates	(4 pages)
04 Dec 2019	TM01	Termination of appointment of Malcolm David Foster Pye as a director on 30 November 2019	(1 page)
02 Oct 2019	TM01	Termination of appointment of Roland James Bonney as a director on 30 September 2019	(1 page)
24 Jul 2019	MR04	Satisfaction of charge SC2678500007 in full	(1 page)
24 Jul 2019	MR04	Satisfaction of charge SC2678500008 in full	(1 page)
24 Jul 2019	MR04	Satisfaction of charge SC2678500009 in full	(1 page)
19 Jul 2019	AA	Full accounts made up to 30 September 2018	(41 pages)
18 Feb 2019	MR01	Registration of charge SC2678500009, created on 6 February 2019	(21 pages)
05 Dec 2018	CS01	Confirmation statement made on 5 December 2018 with no updates	(3 pages)
01 Oct 2018	TM01	Termination of appointment of Hamish David Macleod Rodger as a director on 28 September 2018	(1 page)
06 Sep 2018	AP04	Appointment of Prism Cosec Limited as a secretary on 20 August 2018	(2 pages)
03 Sep 2018	TM02	Termination of appointment of David Venus & Company Llp as a secretary on 20 August 2018	(1 page)
22 Jun 2018	AA	Full accounts made up to 30 September 2017	(40 pages)
05 Dec 2017	CS01	Confirmation statement made on 5 December 2017 with no updates	(3 pages)
29 Nov 2017	CH01	Director's details changed for Hernan Rinaldo Pizarro Tonini on 15 June 2016	(2 pages)
13 Jun 2017	CC04	Statement of company's objects	(2 pages)
13 Jun 2017	RESOLUTIONS	Resolutions RES10 ‐ Resolution of allotment of securities RES01 ‐ Resolution of adoption of Articles of Association	(28 pages)
31 May 2017	TM01	Termination of appointment of Ruth Layton as a director on 31 May 2017	(1 page)
04 Apr 2017	AA	Full accounts made up to 30 September 2016	(38 pages)
12 Dec 2016	CS01	Confirmation statement made on 5 December 2016 with updates	(6 pages)
03 Nov 2016	MA	Memorandum and Articles of Association	(22 pages)
03 Nov 2016	RESOLUTIONS	Resolutions RES13 ‐ That the execution, entry into, delivery and performance by the company of its obligations under the banking documents are hereby approved. 23/02/2016 RES01 ‐ Resolution of alteration of Articles of Association	(5 pages)
13 Oct 2016	CH01	Director's details changed for Mr Malcolm David Foster Pye on 1 April 2016	(2 pages)